WALTHAM, Mass.--(BUSINESS WIRE)--Apr. 13, 2009-- Phase Forward (NASDAQ: PFWD), a leading provider of data management solutions for clinical trials and drug safety, will participate at five upcoming industry events this month: CDISC European Interchange, ACRP 2009 Global Conference, Midwest Clinical Supplies Group Meeting, Bio-IT World Conference and Expo, and the 18^th Annual Partnerships with CROs Conference. Details are as follows:

What: CDISC European Interchange
When: April 22-23, 2009
Where: Corinthia Grand Hotel Royal in Budapest, Hungary
Session: "HL7 & RIM - An Introduction to Non-Technical Professionals," Thursday, April 23, Session 7, Track 1, 1:30 - 3:00 p.m. local time, Joerg Dillert, Principal Consultant, Phase Forward (Panelist)

What: ACRP 2009 Global Conference
When: April 24-28, 2009
Where: Colorado Convention Center in Denver, CO, Booth # 433

What: Midwest Clinical Supplies Group Meeting
When: April 26-29, 2009
Where: Arizona Grand Hotel in Phoenix, AZ

What: Bio-IT World Conference and Expo
When: April 27-29, 2009
Where: World Trade Center in Boston, Mass., Booth # 205

What: 18^th Annual Partnerships with CROs Conference
When: April 28-30, 2009
Where: Rosen Shingle Creek Hotel in Orlando, FL, Booth # 102
Session: "Successfully Applying Technology to Clinical Trials Across World Regions," Wednesday, April 29, Track D, 2:00 - 2:45 p.m. local time, Mike Davies, PhD, Vice President, Global CRO Partnerships, Phase Forward (Panelist)

Members of the media interested in speaking with Phase Forward at the CDISC European Interchange should contact Maria Sumner at +44 1628 640743 or maria.sumner@phaseforward.com, and for all other events Meghan Locke at 781-672-3147 or mlocke@chenpr.com.

About Phase Forward
Phase Forward is a leading provider of integrated data management solutions for clinical trials and drug safety. The company offers proven solutions for electronic data capture (InForm^TM), phase I clinic automation (LabPas^TM), clinical data management (Clintrial^TM), clinical trials signal detection (CTSD^TM), strategic pharmacovigilance (Empirica Signal^TM) and Signal Management, adverse event reporting (Empirica Trace^TM), applied data standards (WebSDM^TM) and Web-integrated interactive response technologies (Clarix^TM). In addition, the company provides services in the areas of application implementation, hosting and validation, data integration, business process optimization, safety data management and industry standards. Phase Forward's products and services have been utilized in over 10,000 clinical trials involving more than 1,000,000 clinical trial study participants at over 280 organizations and regulatory agencies worldwide including: AstraZeneca, Boston Scientific, Dana-Farber Cancer Institute, Eli Lilly, the U.S. Food and Drug Administration, GlaxoSmithKline, Harvard Clinical Research Institute, Merck Serono, Novartis, Novo Nordisk, PAREXEL International, Procter & Gamble, Quintiles, sanofi-aventis, Schering-Plough Research Institute, Servier, Tibotec and the U.K. Medicines and Healthcare Products Regulatory Agency. Additional information about Phase Forward is available at www.phaseforward.com.

Source: Phase Forward

Phase Forward
Elaine Maynard, 781-902-4371
elaine.maynard@phaseforward.com
or
CHEN PR, Inc.
Meghan Locke, 781-672-3147
mlocke@chenpr.com